JP2011520846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520846A5 JP2011520846A5 JP2011508943A JP2011508943A JP2011520846A5 JP 2011520846 A5 JP2011520846 A5 JP 2011520846A5 JP 2011508943 A JP2011508943 A JP 2011508943A JP 2011508943 A JP2011508943 A JP 2011508943A JP 2011520846 A5 JP2011520846 A5 JP 2011520846A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- composition according
- myeloma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08380154.8 | 2008-05-16 | ||
| EP08380154 | 2008-05-16 | ||
| PCT/EP2009/055978 WO2009138509A1 (en) | 2008-05-16 | 2009-05-18 | Multiple myeloma treatments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011520846A JP2011520846A (ja) | 2011-07-21 |
| JP2011520846A5 true JP2011520846A5 (enExample) | 2012-07-05 |
Family
ID=40848780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508943A Pending JP2011520846A (ja) | 2008-05-16 | 2009-05-18 | 多発性骨髄腫の治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8435992B2 (enExample) |
| EP (1) | EP2303274A1 (enExample) |
| JP (1) | JP2011520846A (enExample) |
| KR (1) | KR20110028454A (enExample) |
| CN (1) | CN102065865B (enExample) |
| AU (1) | AU2009248039B2 (enExample) |
| CA (1) | CA2724206A1 (enExample) |
| IL (1) | IL209360A (enExample) |
| MX (1) | MX2010012358A (enExample) |
| NZ (1) | NZ589270A (enExample) |
| RU (1) | RU2519750C2 (enExample) |
| WO (1) | WO2009138509A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7919493B2 (en) | 2000-04-12 | 2011-04-05 | Pharma Mar, S.A. | Anititumoral ecteinascidin derivatives |
| MXPA02011319A (es) | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
| GB0117402D0 (en) | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
| GB0202544D0 (en) | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
| EP2307003A2 (en) * | 2008-05-16 | 2011-04-13 | Pharma Mar S.A. | Combination therapy with pm00104 and another antitumor agent |
| WO2011048210A1 (en) | 2009-10-22 | 2011-04-28 | Pharma Mar, S.A. | PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT |
| KR101471273B1 (ko) * | 2013-01-29 | 2014-12-11 | 인제대학교 산학협력단 | Ｓｏｄ２를 포함하는 보르테조밉 내성 진단용 바이오 마커 조성물 및 이를 이용한 진단 키트 |
| KR101718800B1 (ko) | 2015-01-21 | 2017-03-24 | 주식회사 디알나노 | 약물 및 ｓｉＲＮＡ의 공동―운반용 나노복합체 및 이의 용도 |
| TWI807411B (zh) | 2017-04-27 | 2023-07-01 | 西班牙商瑪製藥股份有限公司 | 抗腫瘤化合物 |
| US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074243C (zh) * | 1997-09-16 | 2001-11-07 | 林禾杰 | 对虾养殖方法 |
| US6124292A (en) | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
| AR035842A1 (es) * | 1999-05-14 | 2004-07-21 | Pharma Mar Sa | Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo |
| US6569859B1 (en) | 2000-02-22 | 2003-05-27 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
| MXPA02011319A (es) | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
| GB0229793D0 (en) | 2002-12-20 | 2003-01-29 | Pharma Mar Sa | The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| NZ541611A (en) * | 2003-03-12 | 2008-04-30 | Dana Farber Cancer Inst Inc | Aplidine for multiple myeloma treatment |
| GB0522082D0 (en) * | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
| TW200801513A (en) | 2006-06-29 | 2008-01-01 | Fermiscan Australia Pty Ltd | Improved process |
| GB0708691D0 (en) * | 2007-05-04 | 2007-06-13 | Pharma Mar Sa | Anticancer treatments a |
-
2009
- 2009-05-18 CN CN2009801229778A patent/CN102065865B/zh not_active Expired - Fee Related
- 2009-05-18 NZ NZ589270A patent/NZ589270A/en not_active IP Right Cessation
- 2009-05-18 US US12/992,754 patent/US8435992B2/en not_active Expired - Fee Related
- 2009-05-18 WO PCT/EP2009/055978 patent/WO2009138509A1/en not_active Ceased
- 2009-05-18 CA CA2724206A patent/CA2724206A1/en not_active Abandoned
- 2009-05-18 JP JP2011508943A patent/JP2011520846A/ja active Pending
- 2009-05-18 MX MX2010012358A patent/MX2010012358A/es active IP Right Grant
- 2009-05-18 EP EP09745841A patent/EP2303274A1/en not_active Withdrawn
- 2009-05-18 RU RU2010151660/14A patent/RU2519750C2/ru not_active IP Right Cessation
- 2009-05-18 AU AU2009248039A patent/AU2009248039B2/en not_active Ceased
- 2009-05-18 KR KR1020107028257A patent/KR20110028454A/ko not_active Abandoned
-
2010
- 2010-11-16 IL IL209360A patent/IL209360A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011520846A5 (enExample) | ||
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| TW200640908A (en) | Chemical compounds | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| JP2012255026A5 (enExample) | ||
| MX2010003868A (es) | Cis-imidazolinas quirales. | |
| MX2010009163A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211. | |
| UA96964C2 (ru) | Соединения полициклической мочевины с антибактериальными свойствами | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| UA109417C2 (uk) | ЗАМІЩЕНІ ПІПЕРИДИНИ, ЯКІ ПІДВИЩУЮТЬ АКТИВНІСТЬ p53, І ЇХ ЗАСТОСУВАННЯ | |
| RU2020107416A (ru) | Комбинация, содержащая палбоциклиб и 6-(2,4-дихлорфенил)-5-[4-[(3s)-1-(3-фторпропил)пиррролидин-3-ил]-8,9-дигидро-7h-бензо[7]аннулен-2-карбоновую кислоту, и ее применение для лечения рака | |
| MX2010009395A (es) | Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procesos para preparacion de los mismos. | |
| RU2010151660A (ru) | Способы лечения множественной миеломы | |
| TW200643013A (en) | Pyrazoles | |
| MX2014014969A (es) | Combinacion de un inhibidor de la 17-alfa-hidroxilasa (c17,20-liasa) y un inhibidor especifico de la pi-3k para tratar una enfermedad tumoral. | |
| TN2015000386A1 (en) | Formulations of organic compounds | |
| MX2010013310A (es) | Derivados de heterociclil urea para el tratamiento de infecciones bacterianas. | |
| SA519401614B1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
| WO2014110353A8 (en) | Notch ligand bound biocompatible substrates and their use in bone formation | |
| WO2016100949A3 (en) | Method and compositions for dissolving or solubilizing therapeutic agents | |
| JP2016515550A5 (enExample) | ||
| MX2010009756A (es) | Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos. | |
| EA200601901A1 (ru) | Композиции, содержащие иммуномодулирующие соединения для лечения и управления течением миелодиспластических синдромов и способы с их использованием | |
| JP2015507020A5 (enExample) | ||
| NI200700031A (es) | Formulaciones de ácido hidroxamico suberoilanilida y procedimientos para la producción de las mismas |